Form 4: CONMED Corp Director Martha Goldberg Aronson Acquires 2,000 Shares
SEC Form 4 Filing
Director Martha Goldberg Aronson purchased 2,000 shares of CONMED Corp common stock at an average price of $70.98 on May 6, 2024.
Summary
- On May 6, 2024, Martha Goldberg Aronson, a director of CONMED Corp, acquired 2,000 shares of common stock.
- The shares were purchased at a weighted average price of $70.98, with individual transaction prices ranging from $70.92 to $71.19.
- The purchase was made indirectly through an IRA.
- Following the transaction, Ms. Aronson directly owns 11,610 shares and indirectly owns 2,000 shares.
- A power of attorney was previously established on September 13, 2023, authorizing certain individuals to execute filings on Ms. Aronson's behalf.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard transaction report, with the director's stock purchase leaning slightly positive.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of insider trading activity and are used by the SEC to monitor potential illegal activity. Purchases by insiders are generally seen as a positive sign for the company.
Key Dates
| Date | Description |
|---|---|
| 2023-09-13 | Date of the Limited Power of Attorney execution. |
| 2024-05-06 | Date of the stock purchase transaction. |
| 2024-05-08 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.